1. Home
  2. OFIX vs MRVI Comparison

OFIX vs MRVI Comparison

Compare OFIX & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$12.72

Market Cap

473.3M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.28

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
MRVI
Founded
1987
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.3M
472.8M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
OFIX
MRVI
Price
$12.72
$3.28
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$17.25
$4.13
AVG Volume (30 Days)
231.3K
1.9M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
14.29
EPS
N/A
N/A
Revenue
$822,312,000.00
$185,743,000.00
Revenue This Year
$6.10
$12.44
Revenue Next Year
$6.24
$7.90
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$10.25
$1.67
52 Week High
$16.99
$4.11

Technical Indicators

Market Signals
Indicator
OFIX
MRVI
Relative Strength Index (RSI) 60.70 57.59
Support Level $12.33 $3.25
Resistance Level $16.38 $3.93
Average True Range (ATR) 0.41 0.16
MACD 0.19 0.04
Stochastic Oscillator 85.48 86.11

Price Performance

Historical Comparison
OFIX
MRVI

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: